Ironwood Pharmaceuticals, Inc. (IRWD) Stock
Fundamentals
Latest news
About Ironwood Pharmaceuticals, Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Thomas A. McCourt | CEO & Director | 1957 |
| Ms. Tammi Gaskins | Senior Vice President & Chief Commercial Officer. | 1973 |
| Mr. Ronald Silver | Senior VP, Interim CFO, Corporate Controller & Chief Accounting Officer | 1982 |
| Dr. Rosario Lobrutto M.B.A., M.S., Ph.D. | VP & Global Head of Technical Operations | — |
| Mr. Chris Stamm | Vice President of Investor Relations & Communications | — |
| Mr. John Minardo | Senior VP, Chief Legal Officer & Secretary | 1976 |
| Mr. Jeff Ruberti | Chief Strategy Officer | — |
| Dr. Jeffrey Silber M.D. | Chief Medical Officer, Head of Research & Drug Development | — |



